Ask who actually made the pill behind Cialis Sublingual, and most people would name one of the household pharmaceutical giants. The real answer is far stranger. Tadalafil was developed by a small biotech startup near Seattle — a company whose single largest shareholder happened to be Bill Gates.

A Startup, Not a Giant

The company was ICOS, founded around 1990 in Bothell, Washington, by veterans of the early biotech boom — including the man who had been the founding chief executive of Amgen. It took its name from a twenty-sided geometric shape, and for much of its life it was chasing the science of inflammation and the immune system rather than anything to do with men's health. It was emphatically not a household pharma name.

The Billionaire on the Cap Table

Here's the detail that stops people. When ICOS raised its early money, Bill Gates was among the investors — and, in fact, its biggest shareholder, holding around a tenth of the company. So one of the most famous fortunes in technology helped bankroll the firm that would go on to produce the long-acting "weekend pill." That odd bit of history is woven right into the unlikely origins of tadalafil.

How It Actually Came Together

The molecule itself emerged from a research collaboration ICOS had struck with the drug maker Glaxo. Once Viagra exploded onto the scene, ICOS recognized that its own compound had the same kind of potential — and when Glaxo eventually walked away from the partnership, ICOS joined forces with Eli Lilly to finish the job and bring the drug to market as Cialis in the early 2000s, positioned as the long-lasting challenger to the blue pill.

A Company That Lived and Died on One Drug

What's almost poignant is how the story ended. ICOS's other experimental drugs failed in late testing, and Cialis turned out to be the only product it ever got approved. In 2007, Eli Lilly bought the whole company for around two billion dollars and wound its operations down. In a real sense, that Seattle-area startup existed to give the world one very famous pill — and then was absorbed by the partner that helped sell it.

So here's the trivia worth keeping: the long-lasting rival to Viagra wasn't dreamed up inside a pharmaceutical colossus at all. It came from a scrappy biotech with a software billionaire as its biggest backer — proof that blockbuster medicines, like the prescription tadalafil still is today, don't always come from where you'd expect.